Author(s):
Sejal Patel, Anita P. Patel
Email(s):
patelsejal90@gmail.com
DOI:
10.52711/0974-360X.2021.00712 
Address:
Sejal Patel*, Anita P. Patel
Dep. of Pharmaceutics, Nootan Pharmacy College, Faculty of Pharmacy, Sankalchand Patel University, Visnagar, Gujarat, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 8,
Year - 2021
ABSTRACT:
In the interest of administration of dosage form oral route is most desirable and preferred method. After oral administration to get maximum therapeutic effect, major challenge is their water solubility. Water insoluble drug indicate insufficient bioavailability as well dissolution resulting in fluctuating plasma level. Benidipine (BND) is poorly water soluble antihypertensive drug has lower bioavailability. To improve bioavailability of Benidipine HCL, BND nanosuspension was formulated using media milling technique. HPMC E5 was used to stabilize nanosuspension. The effect of different important process parameters e.g. selection of polymer concentration X1(1.25 mg), stirring time X2 (800 rpm), selection of zirconium beads size X3 (0.4mm) were investigated by 23 factorial design to accomplish desired particle size and saturation solubility. The optimized batch had 408 nm particle size Y1, and showed in-vitro dissolution Y2 95±0.26 % in 30 mins and Zeta potential was -19.6. Differential scanning calorimetry (DSC) and FT-IR analysis was done to confirm there was no interaction between drug and polymer.
Cite this article:
Sejal Patel, Anita P. Patel. Formulation and Evaluation of Benidipine Nanosuspension. Research Journal of Pharmacy and Technology. 2021; 14(8):4111-6. doi: 10.52711/0974-360X.2021.00712
Cite(Electronic):
Sejal Patel, Anita P. Patel. Formulation and Evaluation of Benidipine Nanosuspension. Research Journal of Pharmacy and Technology. 2021; 14(8):4111-6. doi: 10.52711/0974-360X.2021.00712 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-8-18
REFERENCE:
1. Jethara IS, Patel DA, Patel RM, Patel SM, Patel RK, Recent Survey on Nanosuspension: A Patent Overview. Recent Pat Drug Deliv Formul. 2015; 9(1): 65-78.
2. Kumar S, Singh P. Various techniques for solubility enhancement : An overview. Pharma Innov J 2016; 5(1): 23-8.
3. Junghanns JUAH, Müller RH. Nanocrystal technology, drug delivery and clinical applications, International Journal of Nanomedicine 2008; 3(3): 295-310.
4. Irache JM, Esparza I, Gamazo C, Agueros M, Espuelas S. Nanomedicine: Novel approaches in human and veterinary therapeutics. Veterinary Parasitology 2011; 180(1-2): 47-71.
5. Loftsson T, Brewster ME. Pharmaceutical applications of cyclodextrins: Effects on drug permeation through biological membranes. J Pharm Pharmacol 2011; 63(9): 1119-35.
6. Kanthamneni N, Sharma S, Meenach SA, Billet B, Zhao JC, Bachelder EM, et al. Enhanced stability of horseradish peroxidase encapsulated in acetalated dextran microparticles stored outside cold chain conditions. Int J Pharm 2012; 431(1-2): 101-10.
7. Lawrence MJ, Rees GD. Microemulsion‑based media as novel drug delivery systems. Adv Drug Deliv Rev 2000; 45(1): 89-121.
8. Kanthamneni N, Chaudhary A, Wang J, Prabhu S. Nanoparticulate delivery of novel drug combination regimens for the chemoprevention of colon cancer. Int J Oncol 2010; 37(1): 177-85.
9. Picraux T. Nanotechnology. In: Encyclopedia Britannica Deluxe Edition; Encyclopedia Britannica: Chicago, IL, USA, 2010.
10. Wolfgang S. “Sample Preparation” in Light Scattering from Polymer Solutions and Nanoparticle Dispersions Springer Berlin Heidelberg. 2007; 43-44.
11. Y.Kozo, K Nagashima, and M. Hiroyuki. Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker. Journal of Pharmacological Sciences 2006: 100(4); 243-261.
12. Patravale V.B, Date A.A, Kulkarni R.M. Nanosuspensions: A Promising Drug Delivery Strategy. Journal of Pharmacy Pharmacology. 2004: 56(7); 827-840.
13. Ghosh I, Bose S, Vippagunta R, Harmon F. Nanosuspension for Improving the Bioavailability of a Poorly Soluble Drug and Screening of Stabilizing Agents to Inhibit Crystal Growth. International Journal of Pharmaceutics. 2011; 409(1-2); 260-268.
14. Hennart S.L.A, Domingues M, Van hee P. Study of the process of stirred ball milling of poorly water soluble organic products using factorial design. 2010: 198(1); 56-60.